Literature DB >> 32990239

[Investigation of anxiety and depression in patients from the emergency department during COVID-19 epidemic].

Qingxia Wang1, Xiaoxia Cao2, Xiuying Wu3, Jiangfeng Liu4, Jingwen Xie4, Deren Hou4.   

Abstract

OBJECTIVE: To investigate the status of anxiety and depression in patients requiring emergency treatment during the epidemic of COVID-19 to identify the patients with acute psychological stress disorder.
METHODS: During the COVID-19 epidemic, the medical staff divided the patients visiting the emergency department into suspected group, fever group and control group through interview of the patients at triage. Self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were distributed to each patient, and a trained medical staff was responsible for assisting the patient to complete the scales.
RESULTS: A total of 557 sets of scales were distributed, including 211 in suspected COVID-19 case group, 167 in fever group and 179 in the control group. A total of 516 scales were retrieved, including 197 in suspected case group, 151 in fever group and 168 in control group. In the 3 groups, the incidence rates of anxiety and depression were 57.87% and 58.88%, 48.34% and 43.71%, and 18.31% and 18.99%, respectively, and the rates were significantly higher in suspected group and fever group than in the control group (P < 0.01), and significantly higher in suspected group than in fever group (P < 0.05). The standardized anxiety and depression scale scores in suspected case group, fever group and control group were 57.38±16.25 and 42.58±14.27, 51.23±15.29 and 38.32±15.39, and 32.58±17.8 and 12.25±12.94, respectively. Compared with the control group, both suspected case group and fever group had significantly higher standard scores for anxiety and depression (P < 0.01), and suspected case group had significantly higher standardized scores than fever group (P < 0.01).
CONCLUSIONS: Among the patients visiting the emergency treatment, the patients with suspected COVID-19 and common fever are more likely to develop anxiety and depressive symptoms.

Entities:  

Keywords:  COVID-19; acute psychological stress disorder; self-rating anxiety scale; self-rating depression scale

Mesh:

Year:  2020        PMID: 32990239      PMCID: PMC7544584          DOI: 10.12122/j.issn.1673-4254.2020.09.23

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  2 in total

1.  Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study.

Authors:  Harvey Moldofsky; John Patcai
Journal:  BMC Neurol       Date:  2011-03-24       Impact factor: 2.474

2.  Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS).

Authors:  Kitty K Wu; Sumee K Chan; Tracy M Ma
Journal:  J Trauma Stress       Date:  2005-02
  2 in total
  2 in total

Review 1.  The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19.

Authors:  Xuedong An; YueHong Zhang; Liyun Duan; Shenghui Zhao; RongRong Zhou; Yingying Duan; Fengmei Lian; Xiaolin Tong
Journal:  Biomed Pharmacother       Date:  2021-01-14       Impact factor: 7.419

2.  Experiences of Patients Undergoing Emergency Surgery in Covid-19 Pandemic: A Qualitative Study.

Authors:  Fatma Yayla; Araz Askeroğlu
Journal:  J Patient Exp       Date:  2022-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.